01:49 PM EDT, 04/02/2025 (MT Newswires) -- Health care stocks advanced Wednesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both rising 0.4%.

The iShares Biotechnology ETF (IBB) climbed 1.6%.

In corporate news, Johnson & Johnson ( JNJ ) completed its purchase of Intra-Cellular Therapies. The deal is expected to reduce 2025 adjusted earnings by $0.25 a share versus a previous estimate of $0.30 to $0.35, the company said. Johnson & Johnson ( JNJ ) shares rose 1.1%.